Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita

Pediatric Transplantation

Volumn 15, Issue 2, 2011, Pages 161-166

  Nishio, Nobuhiro ^a   Takahashi, Yoshiyuki ^a   Ohashi, Haruhiko ^b   Doisaki, Sayoko ^a   Muramatsu, Hideki ^a   Hama, Asahito ^a   Shimada, Akira ^a   Yagasaki, Hiroshi ^c   Kojima, Seiji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

dyskeratosis congenita; non myeloablative hematopoietic stem cell transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; DYSKERIN; FLUDARABINE; GANCICLOVIR; HLA B ANTIGEN; HLA DR ANTIGEN; LYMPHOCYTE ANTIBODY; MELPHALAN; METHOTREXATE; RITUXIMAB; TACROLIMUS; TELOMERASE REVERSE TRANSCRIPTASE; THYMOCYTE ANTIBODY;

ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; CASE REPORT; CHILD; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DISEASE COURSE; DRUG DOSE REDUCTION; DYSKERATOSIS CONGENITA; FEMALE; FOLLOW UP; GENE MUTATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LEUKOPLAKIA; MALE; NAIL DYSTROPHY; PANCYTOPENIA; PIGMENT DISORDER; PNEUMOCYSTIS PNEUMONIA; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; TELOMERE;

ADOLESCENT; CHILD; DISEASE-FREE SURVIVAL; DYSKERATOSIS CONGENITA; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MONITORING, PHYSIOLOGIC; PREOPERATIVE CARE; RISK ASSESSMENT; SAMPLING STUDIES; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951633240     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01431.x     Document Type: Article

References (33)

1. Walne AJ, Dokal I,. Advances in the understanding of dyskeratosis congenita. Br J Haematol 2009: 145: 164-172.
2. Dokal I, Vulliamy T,. Inherited aplastic anaemias/bone marrow failure syndromes. Blood Rev 2008: 22: 141-153.
3. De La Fuente J, Dokal I,. Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant 2007: 11: 584-594. (Pubitemid 47174390)
4. Alter BP, Giri N, Savage SA, Rosenberg PS,. Cancer in dyskeratosis congenita. Blood 2009: 113: 6549-6557.
5. Johansson JE, Brune M, Ekman T,. The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning. Bone Marrow Transplant 2001: 28: 737-742. (Pubitemid 33085566)
6. Liang J, Yagasaki H, Kamachi Y, et al. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia. Haematologica 2006: 91: 656-658. (Pubitemid 43799463)
7. Hoshino Y, Kimura H, Tanaka N, et al. Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation. Br J Haematol 2001: 115: 105-111. (Pubitemid 32995102)
8. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980: 69: 204-217. (Pubitemid 10036817)
9. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995: 15: 825-828.
10. Schmid I, Stachel D, Pagel P, Albert MH,. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2008: 14: 438-444. (Pubitemid 351372749)
11. Nishio N, Yagasaki H, Takahashi Y, et al. Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children. Pediatr Transplant 2009: 13: 831-837.
12. Shaw PH, Haut PR, Olszewski M, Kletzel M,. Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: One center's experience. Pediatr Transplant 1999: 3: 315-321. (Pubitemid 29503277)
13. Lau YL, Ha SY, Chan CF, Lee AC, Liang RH, Yuen HL,. Bone marrow transplant for dyskeratosis congenita. Br J Haematol 1999: 105: 571. (Pubitemid 29232194)
14. Rocha V, Devergie A, Socie G, et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 1998: 103: 243-248. (Pubitemid 28470826)
15. Yabe M, Yabe H, Hattori K, et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997: 19: 389-392. (Pubitemid 27096073)
16. Langston AA, Sanders JE, Deeg HJ, et al. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol 1996: 92: 758-765. (Pubitemid 26076778)
17. Dokal I, Bungey J, Williamson P, Oscier D, Hows J, Luzzatto L,. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood 1992: 80: 3090-3096. (Pubitemid 23004512)
18. Berthou C, Devergie A, D'Agay MF, et al. Late vascular complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 1991: 79: 335-336.
19. Mahmoud HK, Schaefer UW, Schmidt CG, Becher R, Gotz GF, Richter HJ,. Marrow transplantation for pancytopenia in dyskeratosis congenita. Blut 1985: 51: 57-60. (Pubitemid 15068085)
20. Ghavamzadeh A, Alimoghadam K, Nasseri P, Jahani M, Khodabandeh A, Ghahremani G,. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Bone Marrow Transplant 1999: 23: 299-301. (Pubitemid 29078346)
21. Ayas M, Al-Musa A, Al-Jefri A, et al. Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin. Pediatr Blood Cancer 2007: 49: 103-104. (Pubitemid 46847077)
22. Gungor T, Corbacioglu S, Storb R, Seger RA,. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita. Bone Marrow Transplant 2003: 31: 407-410. (Pubitemid 36410689)
23. Nobili B, Rossi G, De Stefano P, et al. Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen. Br J Haematol 2002: 119: 573-574. (Pubitemid 35365517)
24. Dror Y, Freedman MH, Leaker M, et al. Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita. Bone Marrow Transplant 2003: 31: 847-850. (Pubitemid 36675739)
25. Brazzola P, Duval M, Fournet JC, Gauvin F, Dalle JH, Champagne J, Champagne MA,. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Bone Marrow Transplant 2005: 36: 1103-1105. (Pubitemid 43078140)
26. Dietz AC, Orchard PJ, Baker KS, et al. Disease-specific hematopoietic cell transplantation: Nonmyeloablative conditioning regimen for dyskeratosis congenita. Bone Marrow Transplant 2010: in press.
27. Shimamura A, Alter BP,. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010: 24: 101-122.
28. Bacigalupo A, Locatelli F, Lanino E, et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: A report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005: 36: 947-950. (Pubitemid 41741556)
29. Pasquini R, Carreras J, Pasquini MC, et al. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: Comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant 2008: 14: 1141-1147.
30. Bhatla D, Davies SM, Shenoy S, et al. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplant 2008: 42: 159-165.
31. Ostronoff M, Florencio R, Campos G, et al. Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia. Bone Marrow Transplant 2004: 34: 371-372. (Pubitemid 39172447)
32. Mehta P, Locatelli F, Stary J, Smith FO,. Bone marrow transplantation for inherited bone marrow failure syndromes. Pediatr Clin North Am 2010: 57: 147-170.
33. Finke J, Schmoor C, Lang H, Potthoff K, Bertz H,. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. J Clin Oncol 2003: 21: 506-513. (Pubitemid 46606481)